Trial Profile
A pharmacokinetic study of FT-227 compared with Jurnista in subjects under fed conditions
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Jul 2015
Price :
$35
*
At a glance
- Drugs Hydromorphone (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Flamel Technologies
- 06 Jul 2015 New trial record
- 29 Jun 2015 Results published in a Flamel Technologies Media Release.